{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5b0fd1107b67904376d520f7/5f0eeb0db0d52f31f5d2e917?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Vaccine hopes lift FTSE 100 and we explore what this could mean for London's 'COVID-19 shares'","description":"<p>The FTSE 100 jumps on news Moderna vaccine trials have yielded positive results. We explore what this could mean for the shares listed in London who have enjoyed a sharp rally based on operations focused on COVID-19.</p><p><br></p><p>There is also consideration paid to developments at Tertiary Minerals and Versarien.</p><p><br></p><p><br></p><p>Avacta (LON:AVCT)</p><p>Tertiary Minerals (LON:TYM)</p><p>Versarien (LON:VRS)</p><p>Open Orphan (LON:ORPH)</p>","author_name":"UK Investor Magazine"}